Previous 10 | Next 10 |
Gainers: Kaixin (NASDAQ:KXIN) +50%. Sphere 3D (NASDAQ:ANY) +42%. Westport Fuel Systems (NASDAQ:WPRT) +25%. SCWorx (NASDAQ:WORX) +24%. Aurinia Pharmaceuticals (NASDAQ:AUPH) +22%. LiveRamp Holdings (NYSE:RAMP) +20%. Grid Dynamics (NASDAQ:GDYN) +19%. Bit Digital (NASDAQ:BTBT) +19%. Switch (NYSE:...
Gainers: SCWorx (NASDAQ:WORX) +28%, Aurinia Pharmaceuticals (NASDAQ:AUPH) +21%, BeyondSpring (NASDAQ:BYSI) +13%, Intersect ENT (NASDAQ:XENT) +12%, Caribou Biosciences (NASDAQ:CRBU) +11%. Losers: Dicerna Pharmaceuticals (NASDAQ:DRNA) -35%, iCAD (NAS...
Image source: The Motley Fool. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q2 2021 Earnings Call Aug 5, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcr...
Sphere 3D Corp (NASDAQ:ANY) +43% agreement to acquire exclusive rights for assignment of cryptocurrency mining assets Kaixin Auto (NASDAQ:KXIN) +23% on foraying into new energy vehicle business Switch (NYSE:SWCH) +19% on Q2 earnings Westport Fuel (NASDAQ:WPRT) +1...
Aurinia Pharmaceuticals (NASDAQ:AUPH) continues its yesterday's post-market rally and is up 14.7% premarket after it reported financial results for Q2 ended June 30, 2021. The company recorded robust revenue growth of 624% to $6.6M over prior quarter, ahead of analyst estimate of $5...
Aurinia Pharmaceuticals Inc. (AUPH) Q2 2021 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Glenn Schulman - Senior Vice President of Corporate Communications & Investor Relations Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial ...
Aurinia Pharma (NASDAQ:AUPH): Q2 GAAP EPS of -$0.37 misses by $0.01. Revenue of $6.62M (+21966.7% Y/Y) beats by $1.66M. Gross margin for the three and six months ended June 30, 2021 was ~95%. “As we continue to expand patient access to LUPKYNIS across the United States, we anticip...
– $6.6 million in net revenue for the second quarter 2021 (624% increase from first quarter 2021) – – 415 patient start forms (PSFs) received for LUPKYNIS™ during the second quarter (over a 60% increase from the first quarter 2021) and over 800 PSFs recei...
Earnings season continues for Motley Fool investors this week. There are still plenty of great Canadian stocks to buy before a quick boost from hopefully strong earnings. So, here are four I would consider watching as earnings come out August 5 and even buying ahead of time for a quick litt...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its second quarter 2021 financial results on Thursday, August 5, 2021, after the markets close. Aurinia’s management team will also host a conference call at ...
News, Short Squeeze, Breakout and More Instantly...
Aurinia Pharmaceuticals Inc Company Name:
AUPH Stock Symbol:
NASDAQ Market:
Aurinia Pharmaceuticals Inc Website:
Viridien ADR (CGGYD) is expected to report for Q2 2024 Civitas Resources Inc. (CIVI) is expected to report $2.9 for Q2 2024 Aptiv PLC (APTV) is expected to report $1.37 for Q2 2024 Ardelyx Inc. (ARDX) is expected to report $-0.1 for Q2 2024 Beazer Homes USA Inc. (BZH) is expected ...
Company achieved $57.2 million in total net revenue and $55.0 million in net product revenue for the second quarter of 2024, representing year-over-year growth of approximately 38% and 34% respectively Company generated approximately $15.8 million in free cash flow in the second quarter a...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the second quarter of 2024 on Thursday, August 1, 2024, before markets open. Aurinia’s management team will host a conference call/webcast at 8:30...